JESSICA MONTGOMERY MIMS: Open Payments
NPI 1649511247 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 27 payments from 9 companies in 2025. Trend: 2023 $318 · 2024 $392 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $140 |
| Exact Sciences Corporation | 3 | $71 |
| Novo Nordisk Inc | 4 | $68 |
| Amgen Inc. | 4 | $64 |
| PFIZER INC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, Cologuard Collection Kit, JARDIANCE, OTEZLA, ELIQUIS, Wegovy, Ozempic, SHINGRIX.
Industry payments across MO — which companies pay providers there.
